Trans-endothelial migration of carcinoma cells was previously demonstrated to be Rac1 dependent with Rac1 knockdown or single copy deletion in vivo attenuating carcinoma cell trans-endothelial migration and hematogenous spread. Here, RAC1 is linked to carcinoma.